| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accurate Targeting of Daily Intravenous Busulfan with 8-Hour Blood Sampling in Hospitalized Adult Hematopoietic Cell Transplant Recipients
|
Yeh, Rosa F.
|
|
2012
|
18 |
2 |
p. 265-272
8 p.
|
artikel
|
| 2 |
Allogeneic Hematopoietic Cell Transplantation for Chronic Myelofibrosis in Australia and New Zealand: Older Recipients Receiving Myeloablative Conditioning at Increased Mortality Risk
|
Nivison-Smith, Ian
|
|
2012
|
18 |
2 |
p. 302-308
7 p.
|
artikel
|
| 3 |
A Phase I Study of Gemtuzumab Ozogamicin (GO) in Combination with Busulfan and Cyclophosphamide (Bu/Cy) and Allogeneic Stem Cell Transplantation in Children with Poor-Risk CD33+ AML: A New Targeted Immunochemotherapy Myeloablative Conditioning (MAC) Regimen
|
Satwani, Prakash
|
|
2012
|
18 |
2 |
p. 324-329
6 p.
|
artikel
|
| 4 |
2012 BMT Tandem Meetings
|
|
|
2012
|
18 |
2 |
p. 330-
1 p.
|
artikel
|
| 5 |
Classifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center for International Blood and Marrow Transplant Research Study
|
Armand, Philippe
|
|
2012
|
18 |
2 |
p. 280-288
9 p.
|
artikel
|
| 6 |
Contents
|
|
|
2012
|
18 |
2 |
p. A5-A8
nvt p.
|
artikel
|
| 7 |
Dasatinib as Salvage Therapy for Steroid Refractory and Imatinib Resistant or Intolerant Sclerotic Chronic Graft-versus-Host Disease
|
Sánchez-Ortega, Isabel
|
|
2012
|
18 |
2 |
p. 318-323
6 p.
|
artikel
|
| 8 |
Development and Validation of a Test Dose Strategy for Once-Daily i.v. Busulfan: Importance of Fixed Infusion Rate Dosing
|
Kangarloo, S. Bill
|
|
2012
|
18 |
2 |
p. 295-301
7 p.
|
artikel
|
| 9 |
Double Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from the SFGM-TC
|
Bay, J.O.
|
|
2012
|
18 |
2 |
p. 250-256
7 p.
|
artikel
|
| 10 |
Easy-to-Read Informed Consent Forms for Hematopoietic Cell Transplantation Clinical Trials
|
Denzen, Ellen M.
|
|
2012
|
18 |
2 |
p. 183-189
7 p.
|
artikel
|
| 11 |
EBMT Risk Score Predicts Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Who Have Failed a Previous Transplantation Procedure
|
Rezvani, Katayoun
|
|
2012
|
18 |
2 |
p. 235-240
6 p.
|
artikel
|
| 12 |
Editorial Board
|
|
|
2012
|
18 |
2 |
p. A2-
1 p.
|
artikel
|
| 13 |
Effect of Early Posttransplantation Tacrolimus Concentration on the Development of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors
|
Mori, Takehiko
|
|
2012
|
18 |
2 |
p. 229-234
6 p.
|
artikel
|
| 14 |
Genetic Variations in the Mycophenolate Mofetil Target Enzyme Are Associated with Acute GVHD Risk after Related and Unrelated Hematopoietic Cell Transplantation
|
Cao, Weijie
|
|
2012
|
18 |
2 |
p. 273-279
7 p.
|
artikel
|
| 15 |
Identification of a Coordinated CD8 and CD4 T Cell Response Directed Against Mismatched HLA Class I Causing Severe Acute Graft-versus-Host Disease
|
Amir, Avital L.
|
|
2012
|
18 |
2 |
p. 210-219
10 p.
|
artikel
|
| 16 |
Idiotype Immunization Following High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma
|
Holman, Peter R.
|
|
2012
|
18 |
2 |
p. 257-264
8 p.
|
artikel
|
| 17 |
Limiting the Daily Total Nucleated Cell Dose of Cryopreserved Peripheral Blood Stem Cell Products for Autologous Transplantation Improves Infusion-Related Safety with No Adverse Impact on Hematopoietic Engraftment
|
Khera, Nandita
|
|
2012
|
18 |
2 |
p. 220-228
9 p.
|
artikel
|
| 18 |
My AML Cytogenetics Classification Scheme Is Better Than Yours
|
Sekeres, Mikkael A.
|
|
2012
|
18 |
2 |
p. 160-161
2 p.
|
artikel
|
| 19 |
NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Health-Related Quality of Life, Functional, and Neurocognitive Outcomes
|
Parsons, Susan K.
|
|
2012
|
18 |
2 |
p. 162-171
10 p.
|
artikel
|
| 20 |
New Hope for Mobilization Failures . . . Again
|
DiPersio, John F.
|
|
2012
|
18 |
2 |
p. 159-160
2 p.
|
artikel
|
| 21 |
Officers and Directors of ASBMT
|
|
|
2012
|
18 |
2 |
p. A3-
1 p.
|
artikel
|
| 22 |
Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or Lymphoma
|
Attolico, Immacolata
|
|
2012
|
18 |
2 |
p. 241-249
9 p.
|
artikel
|
| 23 |
Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide
|
Malard, Florent
|
|
2012
|
18 |
2 |
p. 314-317
4 p.
|
artikel
|
| 24 |
Purpose and Scope
|
|
|
2012
|
18 |
2 |
p. A1-
1 p.
|
artikel
|
| 25 |
Reduced-Intensity Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: A Report from the SFGM-TC
|
Chevallier, Patrice
|
|
2012
|
18 |
2 |
p. 289-294
6 p.
|
artikel
|
| 26 |
Stable Long-Term Pulmonary Function after Myeloablative Double Cord Blood Transplant
|
Milano, Filippo
|
|
2012
|
18 |
2 |
p. 309-313
5 p.
|
artikel
|
| 27 |
T Cell and B Cell Immunity can be Reconstituted with Mismatched Hematopoietic Stem Cell Transplantation Without Alkylator Therapy in Artemis-Deficient Mice Using Anti-Natural Killer Cell Antibody and Photochemically Treated Sensitized Donor T Cells
|
Xiao, Tony Z.
|
|
2012
|
18 |
2 |
p. 200-209
10 p.
|
artikel
|
| 28 |
The National Marrow Donor Program’s Symposium on Hematopoietic Cell Transplantation in 2020: A Health Care Resource and Infrastructure Assessment
|
Majhail, Navneet S.
|
|
2012
|
18 |
2 |
p. 172-182
11 p.
|
artikel
|
| 29 |
The Pretransplantation Serum Cytokine Profile in Allogeneic Stem Cell Recipients Differs from Healthy Individuals, and Various Profiles are Associated with Different Risks of Posttransplantation Complications
|
Reikvam, Håkon
|
|
2012
|
18 |
2 |
p. 190-199
10 p.
|
artikel
|
Tijdschrift beschrijving